Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management

MZ Handler, PA Patel, R Kapila, Y Al-Qubati… - Journal of the American …, 2015 - Elsevier
The diagnosis of leishmaniasis can be challenging because it mimics both infectious and
malignant conditions. A misdiagnosis may lead to an unfavorable outcome. Using culture …

Treatment of cutaneous leishmaniasis and insights into species-specific responses: a narrative review

RK Madusanka, H Silva, ND Karunaweera - Infectious diseases and …, 2022 - Springer
Cutaneous leishmaniasis (CL) is a complex skin infection that has imposed a heavy burden
on many developing countries and is caused by more than 20 Leishmania species. This …

Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical …

N Aronson, BL Herwaldt, M Libman… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

Chemical composition of Mentha pulegium and Rosmarinus officinalis essential oils and their antileishmanial, antibacterial and antioxidant activities

A Bouyahya, A Et-Touys, Y Bakri, A Talbaui… - Microbial …, 2017 - Elsevier
The aim of the study was the determination of the chemical composition of Mentha pulegium
L. and Rosmarinus officinalis L. essential oils and the evaluation of their antileishmanial …

[HTML][HTML] Fe3O4@ piroctone olamine magnetic nanoparticles: Synthesize and therapeutic potential in cutaneous leishmaniasis

AE Albalawi, AK Khalaf, MS Alyousif, AD Alanazi… - Biomedicine & …, 2021 - Elsevier
Background In recent years, magnetic nanoparticles (NMP) as novel materials have been
widely used for biomedical, diagnostic and therapeutic purposes like microbial infection …

Antileishmanial drug discovery and development: time to reset the model?

AI Olias-Molero, C de la Fuente, M Cuquerella… - Microorganisms, 2021 - mdpi.com
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The
disease affects humans and animals, particularly dogs, provoking cutaneous …

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime®) in Cutaneous Leishmaniasis

AE Albalawi, S Abdel-Shafy, A Khudair Khalaf… - Nanomaterials, 2021 - mdpi.com
Background: In recent years, the focus on nanotechnological methods in medicine,
especially in the treatment of microbial infections, has increased rapidly. Aim: The present …

Current status on prevention and treatment of canine leishmaniasis

RM Reguera, M Moran, Y Perez-Pertejo… - Veterinary …, 2016 - Elsevier
Canine leishmaniasis (CanL) is a parasite-borne disease mainly induced by Leishmania
infantum in the Old World and Leishmania chagasi (infantum) in the New World. CanL is a …

Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016

JMT Bezerra, VEM de Araújo, DS Barbosa… - PLoS neglected …, 2018 - journals.plos.org
Background The study presents estimates for the burden of visceral leishmaniasis (VL) and
cutaneous and mucocutaneous leishmaniasis (CML) in Brazil and its 27 federated units …

Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update

L Reveiz, ANS Maia-Elkhoury, RS Nicholls… - PloS one, 2013 - journals.plos.org
Introduction Leishmaniasis is an important public health problem in the Americas. A
Cochrane review published in 2009 analyzed 38 randomized controlled trials (RCT). We …